|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 201 to 300 out of 517 for Braf

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.037s

Categories

Category: Publication
« show all
Type Details Score
Publication
35422482 | J:324042
First Author: Martens S
Year: 2022
Journal: Cell Death Dis
Title: MLKL deficiency in BrafV600EPten-/- melanoma model results in a modest delay of nevi development and reduced lymph node dissemination in male mice.
Volume: 13
Issue: 4
Pages: 347
•
•
•
•
•
Publication
26477313 | J:312572
First Author: Zou M
Year: 2016
Journal: Oncogene
Title: TSH overcomes Braf(V600E)-induced senescence to promote tumor progression via downregulation of p53 expression in papillary thyroid cancer.
Volume: 35
Issue: 15
Pages: 1909-18
•
•
•
•
•
Publication
33953176 | J:306090
First Author: Di Leo L
Year: 2021
Journal: Nat Commun
Title: Loss of Ambra1 promotes melanoma growth and invasion.
Volume: 12
Issue: 1
Pages: 2550
•
•
•
•
•
Publication
27210757 | J:235959
First Author: Claps G
Year: 2016
Journal: Cell Rep
Title: A Transcriptionally Inactive ATF2 Variant Drives Melanomagenesis.
Volume: 15
Issue: 9
Pages: 1884-92
•
•
•
•
•
Publication
26657898 | J:229687
First Author: Köhler M
Year: 2016
Journal: EMBO J
Title: Activation loop phosphorylation regulates B-Raf in vivo and transformation by B-Raf mutants.
Volume: 35
Issue: 2
Pages: 143-61
•
•
•
•
•
Publication
28228261 | J:254389
First Author: Cicchini M
Year: 2017
Journal: Cell Rep
Title: Context-Dependent Effects of Amplified MAPK Signaling during Lung Adenocarcinoma Initiation and Progression.
Volume: 18
Issue: 8
Pages: 1958-1969
•
•
•
•
•
Publication
32401131 | J:315835
First Author: Goz RU
Year: 2020
Journal: J Neurophysiol
Title: BRAFV600E expression in neural progenitors results in a hyperexcitable phenotype in neocortical pyramidal neurons.
Volume: 123
Issue: 6
Pages: 2449-2464
•
•
•
•
•
Publication
31452510 | J:278997
   
First Author: van Veen JE
Year: 2019
Journal: Elife
Title: Mutationally-activated PI3'-kinase-α promotes de-differentiation of lung tumors initiated by the BRAFV600E oncoprotein kinase.
Volume: 8
•
•
•
•
•
Publication
31138602 | J:279045
First Author: Kircher DA
Year: 2019
Journal: Mol Cancer Res
Title: AKT1E17K Activates Focal Adhesion Kinase and Promotes Melanoma Brain Metastasis.
Volume: 17
Issue: 9
Pages: 1787-1800
•
•
•
•
•
Publication
30787016 | J:274226
First Author: Fischer GM
Year: 2019
Journal: Cancer Discov
Title: Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases.
Volume: 9
Issue: 5
Pages: 628-645
•
•
•
•
•
Publication
39098861 | J:352960
First Author: Wee Y
Year: 2024
Journal: Nat Commun
Title: Tumour-intrinsic endomembrane trafficking by ARF6 shapes an immunosuppressive microenvironment that drives melanomagenesis and response to checkpoint blockade therapy.
Volume: 15
Issue: 1
Pages: 6613
•
•
•
•
•
Publication
34597611 | J:333928
First Author: Chhabra G
Year: 2022
Journal: J Invest Dermatol
Title: Antimelanoma Effects of Concomitant Inhibition of SIRT1 and SIRT3 in Braf(V600E)/Pten(NULL) Mice.
Volume: 142
Issue: 4
Pages: 1145-1157.e7
•
•
•
•
•
Publication
29438700 | J:257785
First Author: Yu Y
Year: 2018
Journal: Cancer Cell
Title: Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma.
Volume: 33
Issue: 2
Pages: 322-336.e8
•
•
•
•
•
Publication
35267510 | J:327289
 
First Author: Vázquez-Naharro A
Year: 2022
Journal: Cancers (Basel)
Title: Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and Survival.
Volume: 14
Issue: 5
•
•
•
•
•
Publication
22172720 | J:178598
First Author: Damsky WE
Year: 2011
Journal: Cancer Cell
Title: β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas.
Volume: 20
Issue: 6
Pages: 741-54
•
•
•
•
•
Publication
29563610 | J:263999
First Author: Basu SK
Year: 2018
Journal: Oncogene
Title: A RAS-CaMKKβ-AMPKα2 pathway promotes senescence by licensing post-translational activation of C/EBPβ through a novel 3'UTR mechanism.
Volume: 37
Issue: 26
Pages: 3528-3548
•
•
•
•
•
Publication
24019382 | J:204513
First Author: Trejo CL
Year: 2013
Journal: Cancer Res
Title: Mutationally activated PIK3CA(H1047R) cooperates with BRAF(V600E) to promote lung cancer progression.
Volume: 73
Issue: 21
Pages: 6448-61
•
•
•
•
•
Publication
31048499 | J:276334
First Author: Yoo JH
Year: 2019
Journal: Cancer Res
Title: The Small GTPase ARF6 Activates PI3K in Melanoma to Induce a Prometastatic State.
Volume: 79
Issue: 11
Pages: 2892-2908
•
•
•
•
•
Publication
26565903 | J:228953
First Author: Cho JH
Year: 2015
Journal: Cell Rep
Title: AKT1 Activation Promotes Development of Melanoma Metastases.
Volume: 13
Issue: 5
Pages: 898-905
•
•
•
•
•
Publication
24589553 | J:209631
First Author: Juan J
Year: 2014
Journal: Genes Dev
Title: Diminished WNT -> β-catenin -> c-MYC signaling is a barrier for malignant progression of BRAFV600E-induced lung tumors.
Volume: 28
Issue: 6
Pages: 561-75
•
•
•
•
•
Publication
22511580 | J:189336
First Author: Trejo CL
Year: 2012
Journal: Cancer Res
Title: MEK1/2 inhibition elicits regression of autochthonous lung tumors induced by KRASG12D or BRAFV600E.
Volume: 72
Issue: 12
Pages: 3048-59
•
•
•
•
•
Publication
26001956 | J:225607
First Author: Shai A
Year: 2015
Journal: Cancer Res
Title: TP53 Silencing Bypasses Growth Arrest of BRAFV600E-Induced Lung Tumor Cells in a Two-Switch Model of Lung Tumorigenesis.
Volume: 75
Issue: 15
Pages: 3167-80
•
•
•
•
•
Publication
32792685 | J:296235
First Author: Reischmann N
Year: 2020
Journal: Oncogene
Title: BRAFV600E drives dedifferentiation in small intestinal and colonic organoids and cooperates with mutant p53 and Apc loss in transformation.
Volume: 39
Issue: 38
Pages: 6053-6070
•
•
•
•
•
Publication
27683179 | J:350188
First Author: Zhang KJ
Year: 2017
Journal: Clin Cancer Res
Title: A Potent In Vivo Antitumor Efficacy of Novel Recombinant Type I Interferon.
Volume: 23
Issue: 8
Pages: 2038-2049
•
•
•
•
•
Publication
30467381 | J:349042
First Author: Weng CC
Year: 2019
Journal: Oncogene
Title: Mutant Kras-induced upregulation of CD24 enhances prostate cancer stemness and bone metastasis.
Volume: 38
Issue: 12
Pages: 2005-2019
•
•
•
•
•
Publication
28273450 | J:251063
First Author: Chen CF
Year: 2017
Journal: Cell Rep
Title: ATR Mutations Promote the Growth of Melanoma Tumors by Modulating the Immune Microenvironment.
Volume: 18
Issue: 10
Pages: 2331-2342
•
•
•
•
•
Publication
32579928 | J:292605
First Author: Kamata T
Year: 2020
Journal: Cell Rep
Title: Fibroblast-Derived STC-1 Modulates Tumor-Associated Macrophages and Lung Adenocarcinoma Development.
Volume: 31
Issue: 12
Pages: 107802
•
•
•
•
•
Publication
34348144 | J:311103
First Author: Eshiba S
Year: 2021
Journal: Cell Rep
Title: Stem cell spreading dynamics intrinsically differentiate acral melanomas from nevi.
Volume: 36
Issue: 5
Pages: 109492
•
•
•
•
•
Publication
21478863 | J:247467
First Author: Marquette A
Year: 2011
Journal: Nat Struct Mol Biol
Title: ERK and PDE4 cooperate to induce RAF isoform switching in melanoma.
Volume: 18
Issue: 5
Pages: 584-91
•
•
•
•
•
Publication
22169110 | J:183162
First Author: Packer LM
Year: 2011
Journal: Cancer Cell
Title: Nilotinib and MEK inhibitors induce synthetic lethality through paradoxical activation of RAF in drug-resistant chronic myeloid leukemia.
Volume: 20
Issue: 6
Pages: 715-27
•
•
•
•
•
Publication
31257073 | J:277539
First Author: Lionarons DA
Year: 2019
Journal: Cancer Cell
Title: RAC1P29S Induces a Mesenchymal Phenotypic Switch via Serum Response Factor to Promote Melanoma Development and Therapy Resistance.
Volume: 36
Issue: 1
Pages: 68-83.e9
•
•
•
•
•
Publication
32238882 | J:335346
First Author: Uka R
Year: 2020
Journal: Oncogene
Title: Temporal activation of WNT/β-catenin signaling is sufficient to inhibit SOX10 expression and block melanoma growth.
Volume: 39
Issue: 20
Pages: 4132-4154
•
•
•
•
•
Publication
30664687 | J:295160
First Author: Bagati A
Year: 2019
Journal: Oncogene
Title: KLF9-dependent ROS regulate melanoma progression in stage-specific manner.
Volume: 38
Issue: 19
Pages: 3585-3597
•
•
•
•
•
Publication
36368445 | J:332391
     
First Author: Dong B
Year: 2022
Journal: J Invest Dermatol
Title: FZD6 Promotes Melanoma Cell Invasion but Not Proliferation by Regulating Canonical Wnt Signaling and Epithelial‒Mesenchymal Transition.
•
•
•
•
•
Publication
25472943 | J:221978
First Author: Deuker MM
Year: 2015
Journal: Cancer Discov
Title: PI3'-kinase inhibition forestalls the onset of MEK1/2 inhibitor resistance in BRAF-mutated melanoma.
Volume: 5
Issue: 2
Pages: 143-53
•
•
•
•
•
Publication
27341128 | J:240369
First Author: Das SK
Year: 2016
Journal: Oncotarget
Title: Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis.
Volume: 7
Issue: 30
Pages: 46848-46861
•
•
•
•
•
Publication
23970782 | J:203950
First Author: Shimamura M
Year: 2013
Journal: Endocrinology
Title: Postnatal expression of BRAFV600E does not induce thyroid cancer in mouse models of thyroid papillary carcinoma.
Volume: 154
Issue: 11
Pages: 4423-30
•
•
•
•
•
Publication
33318036 | J:305677
First Author: Saqcena M
Year: 2021
Journal: Cancer Discov
Title: SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation Therapies.
Volume: 11
Issue: 5
Pages: 1158-1175
•
•
•
•
•
Publication
28497782 | J:335349
 
First Author: Dorard C
Year: 2017
Journal: Nat Commun
Title: RAF proteins exert both specific and compensatory functions during tumour progression of NRAS-driven melanoma.
Volume: 8
Pages: 15262
•
•
•
•
•
Publication
32193336 | J:289992
First Author: Sharma S
Year: 2020
Journal: Proc Natl Acad Sci U S A
Title: Targeting the cyclin-dependent kinase 5 in metastatic melanoma.
Volume: 117
Issue: 14
Pages: 8001-8012
•
•
•
•
•
Publication
28658220 | J:249306
First Author: Olmeda D
Year: 2017
Journal: Nature
Title: Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine.
Volume: 546
Issue: 7660
Pages: 676-680
•
•
•
•
•
Publication
39463382 | J:357850
First Author: Soleder S
Year: 2024
Journal: Sci Rep
Title: Development of a novel immunocompetent murine tumor model for urothelial carcinoma using in vivo electroporation.
Volume: 14
Issue: 1
Pages: 25619
•
•
•
•
•
Publication
36672468 | J:332804
 
First Author: Mikheil D
Year: 2023
Journal: Cancers (Basel)
Title: Notch Signaling Suppresses Melanoma Tumor Development in BRAF/Pten Mice.
Volume: 15
Issue: 2
•
•
•
•
•
Publication
24019069 | J:206100
First Author: Lee EK
Year: 2013
Journal: Mol Cell Biol
Title: The FBXO4 tumor suppressor functions as a barrier to BRAFV600E-dependent metastatic melanoma.
Volume: 33
Issue: 22
Pages: 4422-33
•
•
•
•
•
Publication
29993000 | J:265039
First Author: Tokuo H
Year: 2018
Journal: Sci Rep
Title: Myosin X is required for efficient melanoblast migration and melanoma initiation and metastasis.
Volume: 8
Issue: 1
Pages: 10449
•
•
•
•
•
Publication
34140478 | J:307915
First Author: Hamm M
Year: 2021
Journal: Nat Commun
Title: BRN2 is a non-canonical melanoma tumor-suppressor.
Volume: 12
Issue: 1
Pages: 3707
•
•
•
•
•
Publication
29281831 | J:269826
First Author: Tong K
Year: 2017
Journal: Cell Rep
Title: Degree of Tissue Differentiation Dictates Susceptibility to BRAF-Driven Colorectal Cancer.
Volume: 21
Issue: 13
Pages: 3833-3845
•
•
•
•
•
Publication
26837764 | J:231629
First Author: Thiem S
Year: 2016
Journal: Cancer Res
Title: Stomach-Specific Activation of Oncogenic KRAS and STAT3-Dependent Inflammation Cooperatively Promote Gastric Tumorigenesis in a Preclinical Model.
Volume: 76
Issue: 8
Pages: 2277-87
•
•
•
•
•
Publication
23123854 | J:189208
First Author: Mitra D
Year: 2012
Journal: Nature
Title: An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background.
Volume: 491
Issue: 7424
Pages: 449-53
•
•
•
•
•
Publication
26738797 | J:234124
First Author: Whitley MJ
Year: 2016
Journal: Sci Transl Med
Title: A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer.
Volume: 8
Issue: 320
Pages: 320ra4
•
•
•
•
•
Publication
38921956 | J:352253
   
First Author: Gao C
Year: 2024
Journal: Elife
Title: FAK loss reduces BRAF(V600E)-induced ERK phosphorylation to promote intestinal stemness and cecal tumor formation.
Volume: 13
•
•
•
•
•
Publication
27558455 | J:241617
 
First Author: Cammareri P
Year: 2016
Journal: Nat Commun
Title: Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinoma.
Volume: 7
Pages: 12493
•
•
•
•
•
Publication
21383153 | J:170095
First Author: Urosevic J
Year: 2011
Journal: Proc Natl Acad Sci U S A
Title: Constitutive activation of B-Raf in the mouse germ line provides a model for human cardio-facio-cutaneous syndrome.
Volume: 108
Issue: 12
Pages: 5015-20
•
•
•
•
•
Publication
26923591 | J:234363
First Author: Micevic G
Year: 2016
Journal: Cell Rep
Title: DNMT3b Modulates Melanoma Growth by Controlling Levels of mTORC2 Component RICTOR.
Volume: 14
Issue: 9
Pages: 2180-2192
•
•
•
•
•
Publication
36599297 | J:332546
First Author: Tsai CH
Year: 2023
Journal: Cell Metab
Title: Immunoediting instructs tumor metabolic reprogramming to support immune evasion.
Volume: 35
Issue: 1
Pages: 118-133.e7
•
•
•
•
•
Publication
20048081 | J:155731
First Author: Held MA
Year: 2010
Journal: Cancer Res
Title: Characterization of melanoma cells capable of propagating tumors from a single cell.
Volume: 70
Issue: 1
Pages: 388-97
•
•
•
•
•
Publication
26354726 | J:227719
First Author: van der Weyden L
Year: 2016
Journal: J Pathol
Title: Cross-species models of human melanoma.
Volume: 238
Issue: 2
Pages: 152-65
•
•
•
•
•
Publication
27775706 | J:240803
First Author: Moynihan KD
Year: 2016
Journal: Nat Med
Title: Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses.
Volume: 22
Issue: 12
Pages: 1402-1410
•
•
•
•
•
Publication
37270599 | J:354056
First Author: Yang J
Year: 2023
Journal: Mol Cancer
Title: CXCR2 expression during melanoma tumorigenesis controls transcriptional programs that facilitate tumor growth.
Volume: 22
Issue: 1
Pages: 92
•
•
•
•
•
Publication
32686704 | J:298942
First Author: Tagliatela AC
Year: 2020
Journal: Sci Rep
Title: Coronin 1C inhibits melanoma metastasis through regulation of MT1-MMP-containing extracellular vesicle secretion.
Volume: 10
Issue: 1
Pages: 11958
•
•
•
•
•
Publication
32058953 | J:306828
First Author: MacKenzie DJ
Year: 2020
Journal: iScience
Title: DNMT3B Oncogenic Activity in Human Intestinal Cancer Is Not Linked to CIMP or BRAFV600E Mutation.
Volume: 23
Issue: 2
Pages: 100838
•
•
•
•
•
Publication
30581152 | J:270032
First Author: Karras P
Year: 2019
Journal: Cancer Cell
Title: p62/SQSTM1 Fuels Melanoma Progression by Opposing mRNA Decay of a Selective Set of Pro-metastatic Factors.
Volume: 35
Issue: 1
Pages: 46-63.e10
•
•
•
•
•
Publication
28011934 | J:252348
First Author: Dominguez D
Year: 2017
Journal: J Immunol
Title: Exogenous IL-33 Restores Dendritic Cell Activation and Maturation in Established Cancer.
Volume: 198
Issue: 3
Pages: 1365-1375
•
•
•
•
•
Publication
37335131 | J:340270
First Author: Adaku N
Year: 2023
Journal: Cancer Res
Title: Apolipoprotein E2 Stimulates Protein Synthesis and Promotes Melanoma Progression and Metastasis.
Volume: 83
Issue: 18
Pages: 3013-3025
•
•
•
•
•
Publication
34099918 | J:308669
First Author: Jacquelot N
Year: 2021
Journal: Nat Immunol
Title: Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma.
Volume: 22
Issue: 7
Pages: 851-864
•
•
•
•
•
Publication
36107619 | J:331385
 
First Author: Yao W
Year: 2022
Journal: JCI Insight
Title: Keratinocyte-derived cytokine TSLP promotes growth and metastasis of melanoma by regulating the tumor-associated immune microenvironment.
Volume: 7
Issue: 21
•
•
•
•
•
Publication
31375534 | J:289994
First Author: Etzerodt A
Year: 2019
Journal: J Exp Med
Title: Specific targeting of CD163+ TAMs mobilizes inflammatory monocytes and promotes T cell-mediated tumor regression.
Volume: 216
Issue: 10
Pages: 2394-2411
•
•
•
•
•
Publication
27135738 | J:239472
First Author: Souroullas GP
Year: 2016
Journal: Nat Med
Title: An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation.
Volume: 22
Issue: 6
Pages: 632-40
•
•
•
•
•
Publication
28280205 | J:240537
First Author: Yu YQ
Year: 2017
Journal: Science
Title: Molecular and neural basis of contagious itch behavior in mice.
Volume: 355
Issue: 6329
Pages: 1072-1076
•
•
•
•
•
Publication
25848750 | J:227784
First Author: Mann MB
Year: 2015
Journal: Nat Genet
Title: Transposon mutagenesis identifies genetic drivers of Braf(V600E) melanoma.
Volume: 47
Issue: 5
Pages: 486-95
•
•
•
•
•
Publication
25193384 | J:216687
First Author: Martinengo C
Year: 2014
Journal: Cancer Res
Title: ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasis.
Volume: 74
Issue: 21
Pages: 6094-106
•
•
•
•
•
Publication
22000016 | J:177503
First Author: Karreth FA
Year: 2011
Journal: Cell
Title: In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma.
Volume: 147
Issue: 2
Pages: 382-95
•
•
•
•
•
Publication
22043453 | J:185634
First Author: Karreth FA
Year: 2011
Journal: Cancer Discov
Title: C-Raf is required for the initiation of lung cancer by K-Ras(G12D).
Volume: 1
Issue: 2
Pages: 128-36
•
•
•
•
•
Publication
33690225 | J:306045
 
First Author: Huang F
Year: 2021
Journal: J Clin Invest
Title: Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses.
Volume: 131
Issue: 8
•
•
•
•
•
Publication
27068287 | J:247554
   
First Author: Barry DM
Year: 2016
Journal: Mol Pain
Title: Critical evaluation of the expression of gastrin-releasing peptide in dorsal root ganglia and spinal cord.
Volume: 12
•
•
•
•
•
Publication
36131018 | J:335416
First Author: Karras P
Year: 2022
Journal: Nature
Title: A cellular hierarchy in melanoma uncouples growth and metastasis.
Volume: 610
Issue: 7930
Pages: 190-198
•
•
•
•
•
Publication
29343435 | J:272341
First Author: Zhao F
Year: 2018
Journal: Immunity
Title: Paracrine Wnt5a-β-Catenin Signaling Triggers a Metabolic Program that Drives Dendritic Cell Tolerization.
Volume: 48
Issue: 1
Pages: 147-160.e7
•
•
•
•
•
Publication
21441104 | J:277858
First Author: Hu J
Year: 2011
Journal: Proc Natl Acad Sci U S A
Title: Mutation that blocks ATP binding creates a pseudokinase stabilizing the scaffolding function of kinase suppressor of Ras, CRAF and BRAF.
Volume: 108
Issue: 15
Pages: 6067-72
•
•
•
•
•
Publication
38893159 | J:349875
 
First Author: Ghobashi AH
Year: 2024
Journal: Cancers (Basel)
Title: Single-Cell Profiling Reveals the Impact of Genetic Alterations on the Differentiation of Inflammation-Induced Murine Colon Tumors.
Volume: 16
Issue: 11
•
•
•
•
•
Publication
25584893 | J:218894
First Author: Damsky W
Year: 2015
Journal: Cancer Cell
Title: mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formation.
Volume: 27
Issue: 1
Pages: 41-56
•
•
•
•
•
Publication
29490280 | J:271104
First Author: Moore AR
Year: 2018
Journal: Cell Rep
Title: GNA11 Q209L Mouse Model Reveals RasGRP3 as an Essential Signaling Node in Uveal Melanoma.
Volume: 22
Issue: 9
Pages: 2455-2468
•
•
•
•
•
Publication
17967876 | J:128917
First Author: Provot S
Year: 2008
Journal: Mol Cell Biol
Title: A-raf and B-raf are dispensable for normal endochondral bone development, and parathyroid hormone-related peptide suppresses extracellular signal-regulated kinase activation in hypertrophic chondrocytes.
Volume: 28
Issue: 1
Pages: 344-57
•
•
•
•
•
Publication
31685822 | J:281598
First Author: Sun Q
Year: 2019
Journal: Nat Commun
Title: A novel mouse model demonstrates that oncogenic melanocyte stem cells engender melanoma resembling human disease.
Volume: 10
Issue: 1
Pages: 5023
•
•
•
•
•
Publication
19398955 | J:151455
First Author: Goel VK
Year: 2009
Journal: Oncogene
Title: Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice.
Volume: 28
Issue: 23
Pages: 2289-98
•
•
•
•
•
Publication
28506993 | J:241998
First Author: Haston S
Year: 2017
Journal: Development
Title: MAPK pathway control of stem cell proliferation and differentiation in the embryonic pituitary provides insights into the pathogenesis of papillary craniopharyngioma.
Volume: 144
Issue: 12
Pages: 2141-2152
•
•
•
•
•
Publication
27977682 | J:238714
First Author: Pytel D
Year: 2016
Journal: PLoS Genet
Title: PERK Is a Haploinsufficient Tumor Suppressor: Gene Dose Determines Tumor-Suppressive Versus Tumor Promoting Properties of PERK in Melanoma.
Volume: 12
Issue: 12
Pages: e1006518
•
•
•
•
•
Publication
33951424 | J:306664
First Author: DeVito NC
Year: 2021
Journal: Cell Rep
Title: Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy.
Volume: 35
Issue: 5
Pages: 109071
•
•
•
•
•
Publication
1975791 | J:10716
First Author: Justice MJ
Year: 1990
Journal: Genetics
Title: A genetic linkage map of mouse chromosome 10: localization of eighteen molecular markers using a single interspecific backcross.
Volume: 125
Issue: 4
Pages: 855-66
•
•
•
•
•
Publication
2052597 | J:30466
First Author: Miki T
Year: 1991
Journal: Proc Natl Acad Sci U S A
Title: Development of a highly efficient expression cDNA cloning system: application to oncogene isolation.
Volume: 88
Issue: 12
Pages: 5167-71
•
•
•
•
•
Publication
23416466 | J:278578
First Author: Zeng L
Year: 2013
Journal: Cell Signal
Title: RKIP regulates MAP kinase signaling in cells with defective B-Raf activity.
Volume: 25
Issue: 5
Pages: 1156-65
•
•
•
•
•
Publication
37727982 | J:343825
First Author: Zhang J
Year: 2024
Journal: Int J Cancer
Title: Telomere dysfunction in Tert knockout mice delays Braf(V600E) -induced melanoma development.
Volume: 154
Issue: 3
Pages: 548-560
•
•
•
•
•
Publication
24572357 | J:208892
First Author: Hitti FL
Year: 2014
Journal: Nature
Title: The hippocampal CA2 region is essential for social memory.
Volume: 508
Issue: 7494
Pages: 88-92
•
•
•
•
•
Publication
34453124 | J:312445
First Author: Tong K
Year: 2021
Journal: Oncogene
Title: SMAD4 is critical in suppression of BRAF-V600E serrated tumorigenesis.
Volume: 40
Issue: 41
Pages: 6034-6048
•
•
•
•
•
Publication
29033353 | J:253978
First Author: Moon H
Year: 2017
Journal: Cell Stem Cell
Title: Melanocyte Stem Cell Activation and Translocation Initiate Cutaneous Melanoma in Response to UV Exposure.
Volume: 21
Issue: 5
Pages: 665-678.e6
•
•
•
•
•
Publication
34103493 | J:307911
First Author: Leach JDG
Year: 2021
Journal: Nat Commun
Title: Oncogenic BRAF, unrestrained by TGFβ-receptor signalling, drives right-sided colonic tumorigenesis.
Volume: 12
Issue: 1
Pages: 3464
•
•
•
•
•
Publication
25453842 | J:218757
First Author: Zhao ZQ
Year: 2014
Journal: Neuron
Title: Descending control of itch transmission by the serotonergic system via 5-HT1A-facilitated GRP-GRPR signaling.
Volume: 84
Issue: 4
Pages: 821-34
•
•
•
•
•
Publication
23563312 | J:201460
First Author: Hanna SC
Year: 2013
Journal: J Clin Invest
Title: HIF1α and HIF2α independently activate SRC to promote melanoma metastases.
Volume: 123
Issue: 5
Pages: 2078-93
•
•
•
•
•
Publication
24200692 | J:207627
First Author: Marsh Durban V
Year: 2013
Journal: J Clin Invest
Title: Differential AKT dependency displayed by mouse models of BRAFV600E-initiated melanoma.
Volume: 123
Issue: 12
Pages: 5104-18
•
•
•
•
•
Publication
22628411 | J:193065
First Author: Collisson EA
Year: 2012
Journal: Cancer Discov
Title: A central role for RAF→MEK→ERK signaling in the genesis of pancreatic ductal adenocarcinoma.
Volume: 2
Issue: 8
Pages: 685-93
•
•
•
•
•
Publication
28463229 | J:244758
First Author: Olvedy M
Year: 2017
Journal: J Clin Invest
Title: Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanoma.
Volume: 127
Issue: 6
Pages: 2310-2325
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom